|
⚲
|
| Keyboard |
| Caris Halbert LP
✚
|
|
|---|---|
| CIK # | 0002072109 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002072109] | |
| 4 | [0002072109] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Caris Life Sciences Inc | |
| Halbert David D | |
| Caris Halbert LP | |
| Adapt I Ltd | |
| Carisome I LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Caris Life Sciences Inc CAI
Common Stock
|
2025-06-20 | Conversion | 104,761,535 | $0.00 | |
|
Caris Life Sciences Inc CAI
Series B Preferred Stock · derivative
|
2025-06-20 | Conversion | 29,629,630 | ||
|
Caris Life Sciences Inc CAI
Series A Preferred Stock · derivative
|
2025-06-20 | Conversion | 389,416,484 | ||
|
Caris Life Sciences Inc CAI
Common Stock
|
2025-06-18 | Grant | 413,839 | $0.00 | |
|
Caris Life Sciences Inc CAI
Common Stock
|
2025-03-25 | Grant | 360,750 | $0.00 |